Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
ABBOTT LABS-N CHICAGO PLANT | AbbVie | pharmaceuticals | environmental violation | 2004 | EPA | $162,595 |
Pharmacia & Upjohn Company | Pfizer | pharmaceuticals | environmental violation | 2005 | EPA | $676,250 |
Novartis Animal Health US, Inc. | Eli Lilly | pharmaceuticals | environmental violation | 2006 | EPA | $6,500 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | environmental violation | 2006 | EPA | $475,672 |
Alpharma Inc. (Chicago Heights) | Zoetis | pharmaceuticals | environmental violation | 2006 | EPA | $29,737 |
ELI LILLY AND COMPANY | Eli Lilly | pharmaceuticals | environmental violation | 2011 | EPA | $337,500 |
Phibro-Tech, Inc. | Phibro Animal Health | pharmaceuticals | environmental violation | 2008 | EPA | $151,603 |
ELI LILLY & COMPANY - TIPPECANOE LABS | Eli Lilly | pharmaceuticals | environmental violation | 2009 | EPA | $12,000 |
ABBOTT LABS - N. CHICAGO PLANT | AbbVie | pharmaceuticals | environmental violation | 2011 | EPA | $135,756 |
CSL Behring LLC | CSL Limited | pharmaceuticals | environmental violation | 2015 | EPA | $62,780 |
ACTAVIS,INC. | AbbVie | pharmaceuticals | environmental violation | 2015 | EPA | $30,800 |
Pharmacia and Upjohn Company LLC | Pfizer | pharmaceuticals | environmental violation | 2017 | EPA | $34,170 |
Aldrich Chemical | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2018 | EPA | $5,000 |
Aldrich Chemical, LLC | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2018 | EPA | $5,000 |
KREMERS URBAN PHARMACEUTICALS INC | Lannett Co. | pharmaceuticals | environmental violation | 2018 | EPA | $285,000 |
CSL BEHRING LLC | CSL Limited | pharmaceuticals | environmental violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
MALLINCKRODT, INC | Mallinckrodt | pharmaceuticals | environmental violation | 2004 | EPA | $80,160 |
CAMBREX CHARLES CITY, INC | Cambrex | pharmaceuticals | environmental violation | 2006 | EPA | $106,749 |
SIGMA ALDRICH MFG LLC | Merck KGaA (EMD) | pharmaceuticals | environmental violation | 2007 | EPA | $55,000 |
ABBOTT LABORATORIES | Abbott Laboratories | pharmaceuticals | environmental violation | 2008 | EPA | $25,033 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | environmental violation | 2011 | EPA | $900,000 |
BOEHRINGER INGELHEIM VETMEDICA, INC | Eli Lilly | pharmaceuticals | environmental violation | 2012 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $338,475 |
MALLINCKRODT, LLC | Mallinckrodt | pharmaceuticals | environmental violation | 2013 | EPA | $449,740 |
GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
DePuy Synthes | Johnson & Johnson | pharmaceuticals | environmental violation | 2019 | EPA | $51,750 |
Amgen Inc. | Amgen | pharmaceuticals | environmental violation | 2007 | EPA | $24,368 |
Advanced Sterilization Products, Div of Ethicon | Johnson & Johnson | pharmaceuticals | environmental violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $136,800 |
Genentech | Roche | pharmaceuticals | environmental violation | 2023 | EPA | $158,209 |
Janssen Pharmaceutica Inc. | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $7,700 |
NOVARTIS PRODUCTS | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $13,200 |
NOVARTIS CONSUMER HEALTH, INC. | Novartis | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | environmental violation | 2004 | EPA | $5,000 |
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | Bausch Health | pharmaceuticals | benefit plan administrator violation | 2016 | EBSA | $10,001 |
BIOVAIL AMERICAS CORP. | Bausch Health | pharmaceuticals | benefit plan administrator violation | 2012 | EBSA | $10,001 |
CHEROKEE PHARMACEUTICALS LLC | Merck | pharmaceuticals | benefit plan administrator violation | 2011 | EBSA | $10,001 |
NOVARTIS PHARMACEUTICALS CORPORATION | Novartis | pharmaceuticals | benefit plan administrator violation | 2006 | EBSA | $10,001 |
IMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN | Gilead Sciences | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $10,001 |
Seagen Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | benefit plan administrator violation | 2001 | EBSA | $29,974 |
PERNIX THERAPEUTICS, LLC | Currax Pharmaceuticals | pharmaceuticals | benefit plan administrator violation | 2019 | EBSA | $10,001 |
Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | kickbacks and bribery | 2011 | DOJ_CIVIL | $16,000,000 |
Acclarent Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $18,000,000 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | DOJ_CIVIL | $784,600,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Genzyme Corp. | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $22,280,000 |
St. Jude Medical Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $3,650,000 |
Dava Pharmaceuticals Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $126,500,000 |
Eon Labs Inc. | Novartis | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $3,500,000 |
AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Mylan Pharmaceuticals and UDL Laboratories | Viatris | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $118,000,000 |
Ortho McNeil Pharmaceutical | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $3,400,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $95,500,000 |
King Pharmaceuticals | Pfizer | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $124,000,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
Pfizer Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | DOJ_CIVIL | $49,000,000 |
Johnson & Johnson Medical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $3,900,000 |
Sanofi-Pasteur | Sanofi | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $19,868,194 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $465,000,000 |
SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | drug or medical equipment safety violation | 2002 | DOJ_CIVIL | $500,000,000 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | pharmaceuticals | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
United Therapeutics Corporation | United Therapeutics | pharmaceuticals | False Claims Act and related | 2017 | DOJ_CIVIL | $210,000,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2018 | DOJ_CIVIL | $33,200,000 |
Astellas Pharma US Inc. | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $100,000,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $24,750,000 |
DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
Biogen, Inc. | Biogen | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $22,000,000 |
Akorn Operating Company LLC | Akorn Inc. | pharmaceuticals | False Claims Act and related | 2022 | DOJ_CIVIL | $7,900,000 |
Ultragenyx Pharmaceutical Inc. | Ultragenyx Pharmaceutical | pharmaceuticals | False Claims Act and related | 2023 | DOJ_CIVIL | $6,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
Merck KgaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
Apotex Corp. | Apotex Corp. | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2011 | CT-ENV | $20,000 |
Pfizer, Inc. | Pfizer | pharmaceuticals | environmental violation | 2010 | CT-ENV | $31,266 |
Pfizer Inc. | Pfizer | pharmaceuticals | environmental violation | 2006 | CT-ENV | $40,224 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
Pfizer | Pfizer | pharmaceuticals | consumer protection violation | 2022 | CO-AG | $137,174 |
Actavis Kadian, LLC | AbbVie | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $116,703 |
Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $5,641 |
Intermune, Inc. | Roche | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2013 | CMS | $16,215 |
Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2015 | CMS | $5,909 |
Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2015 | CMS | $9,440 |
Amneal Pharmaceutical, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $10,788 |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2016 | CMS | $12,367 |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2019 | CMS | $12,968 |
Wockhardt USA | Wockhardt Limited | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2020 | CMS | $111,824 |
Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2023 | CMS | $31,959 |
Baxalta US, Inc. | Takeda Pharmaceutical | pharmaceuticals | environmental violation | 2017 | CA-SCAQMD | $35,000 |